Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays
About This Grant
The Contractor, Guild Associates, Inc., aims to develop an electrochemical aptamer-based sensor device for simple, rapid, and low-cost detection and quantification of antiretroviral therapy (ART) drugs in urine and blood samples at the point-of-care (POC).
Grant Summary
Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays is a NIMH - National Institute of Mental Health grant providing up to $307K for university, nonprofit, healthcare org. Applications are due 2026-09-29 (open). Check eligibility and apply with FindGrants.
Not quite the right fit?
Search 9,000+ open grants, or get matches ranked for your organization — free.
Focus Areas
Eligibility
How to Apply
Up to $307K
2026-09-29
- 1Confirm your organization is eligible for Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays from NIMH - National Institute of Mental Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to NIMH - National Institute of Mental Health before the deadline.
Don't want to draft it yourself?
We'll draft the complete application against NIMH - National Institute of Mental Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays: Frequently Asked Questions
Who is eligible for the Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays?
Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays is offered by NIMH - National Institute of Mental Health and is generally open to university, nonprofit, healthcare org. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays provide?
Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays provides up to $307K per award from NIMH - National Institute of Mental Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays deadline?
Applications for Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays are due 2026-09-29 (open). Because deadlines can change, verify the date with the funder, NIMH - National Institute of Mental Health, and give yourself enough time to prepare a complete, competitive application before the close date.
How do you apply for the Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays?
To apply for Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from NIMH - National Institute of Mental Health.